[Arterial compliance (stiffness) as a marker of subclinical atherosclerosis]

Jens Nürnberger1, Andres Kribben, Thomas Philipp

  • 1Klinik für Nieren- und Hochdruckkrankheiten, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen. jens.nuernberger@uni-duisburg-essen.de

Herz
|August 10, 2007
PubMed

Insights

Arterial stiffening contributes significantly to cardiovascular disease and mortality. Assessing arterial stiffness using methods like pulse wave velocity can predict future cardiovascular risk and survival.

Area of Science:

  • Cardiovascular physiology and pathophysiology.
  • Biomedical engineering and medical device technology.

Context:

  • Cardiovascular diseases, including coronary heart disease, are primary causes of illness and death in industrialized nations.
  • Arterial wall stiffening is a key pathophysiological mechanism underlying cardiovascular morbidity and mortality.
  • Factors influencing arterial stiffening include age, gender, blood pressure, smoking, hypertension, diabetes, renal failure, and hypercholesterolemia.

Purpose:

  • To review the pathophysiological role of arterial stiffening in cardiovascular disease.
  • To present various models, indices, and techniques for evaluating arterial stiffness.
  • To summarize clinical studies on the predictive value of arterial stiffness markers for cardiovascular risk and survival.

Summary:

  • Arterial stiffness is a significant contributor to cardiovascular morbidity and mortality.
  • Assessment of arterial stiffness, traditionally via pulse wave velocity and increasingly by pulse wave analysis (e.g., augmentation index), is crucial in clinical and epidemiological studies.
  • This review details the mechanisms, measurement techniques, and clinical significance of arterial stiffness.

Impact:

  • Highlights the importance of arterial stiffness as a predictor of cardiovascular events.
  • Provides a comprehensive overview of methods for assessing arterial stiffness.
  • Informs clinical practice and research regarding cardiovascular risk stratification.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...